Detalles de la búsqueda
1.
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors.
Br J Cancer
; 110(5): 1155-62, 2014 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24434430
2.
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer.
Breast Cancer Res Treat
; 140(2): 331-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23868188
3.
Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study.
Br J Cancer
; 106(11): 1722-7, 2012 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22568966
4.
A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network.
Br J Cancer
; 107(2): 280-6, 2012 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22699824
5.
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer.
Invest New Drugs
; 30(3): 1138-43, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21170759
6.
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer.
Ann Oncol
; 21(2): 275-282, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19633042
7.
Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours.
Br J Cancer
; 99(10): 1579-85, 2008 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-19002179
8.
Oxaliplatin-DNA adduct formation in white blood cells of cancer patients.
Br J Cancer
; 98(12): 1959-65, 2008 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-18506148
9.
Chemosensitivity of conjunctival melanoma cell lines to chemotherapeutic agents.
Int J Clin Pharmacol Ther
; 49(1): 78-80, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21176737
10.
Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients.
Int J Clin Pharmacol Ther
; 49(1): 88-90, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21176741
11.
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment.
Int J Clin Pharmacol Ther
; 49(1): 96-8, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21176744
12.
Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.
J Clin Oncol
; 20(23): 4508-16, 2002 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12454106
13.
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications.
Bone Marrow Transplant
; 35(3): 233-41, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15592494
14.
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
Clin Cancer Res
; 4(11): 2701-8, 1998 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-9829732
15.
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.
Clin Cancer Res
; 6(11): 4209-16, 2000 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-11106234
16.
10 Years CESAR Anticancer Drug Research - The 7th CESAR Annual Meeting 2009. Preface.
Int J Clin Pharmacol Ther
; 48(7): 435-9, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20557836
17.
First-line treatment of patients with metastatic pancreatic cancer: results of a Phase II trial with S-1 (CESAR-Study group).
Int J Clin Pharmacol Ther
; 48(7): 470-2, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20557848
18.
Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer.
Int J Clin Pharmacol Ther
; 48(7): 473-5, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20557849
19.
In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy.
Exp Hematol
; 26(12): 1111-7, 1998 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-9808049
20.
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
Eur J Cancer
; 51(1): 27-36, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25459392